Ticker: VKTX

Company: Viking Therapeutics, Inc.

Person: GREG ZANTE, officer

Transaction date: Jan. 2, 2026

Reporting date: Jan. 5, 2026

Average share price: -123.27588932934755

Sold 15388.0 shares for 1896969.39